American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations

2022/12/12 by James Buxbaum, James L. Buxbaum, Martin L. Freeman +23 · 25 citations
Medicine · #Gallbladder and Bile Duct Disorders #Esophageal and GI Pathology #Biliary and Gastrointestinal Fistulas

paper · doi:10.1016/j.gie.2022.10.005

Cited by

• Incidence and Predictors of Incidental Biochemical and Radiologic Pancreatic Alterations Following Uncomplicated ERCP. [europepmc]
• Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials. [europepmc]
• Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial. [europepmc]
• Development and validation of a practical clinical risk prediction model for post-endoscopic retrograde cholangiopancreatography pancreatitis. [europepmc]
• Prediction for post-ERCP pancreatitis in non-elderly patients with common bile duct stones: a cross-sectional study at a major Chinese tertiary hospital (2015-2023). [europepmc]
• American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. [europepmc]
• Computed tomography-based prediction of pancreatitis following biliary metal stent placement with the convolutional neural network. [europepmc]
• Post-endoscopic Retrograde Cholangiopancreatography Hemorrhagic Pancreatitis in a Young Female: A Case Report. [europepmc]
• Aggressive hydration with lactated Ringer's solution versus plasma solution for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (ALPS study): protocol for a multicentre, double-blind, randomised controlled trial. [europepmc]
• Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis. [europepmc]
• Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the SVI Trial Data Set. [europepmc]
• The causality between use of glucocorticoids and risk of pancreatitis: a Mendelian randomization study. [europepmc]
• Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset. [europepmc]
• The efficacy and safety of remimazolam tosilate compared with propofol for endoscopic retrograde cholangiopancreatography under monitored anesthesia care: A single-center randomized controlled clinical trial. [europepmc]
• Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis. [europepmc]
• Pancreatoscopy-Guided Lithotripsy for Pancreatic Duct Stones: A Systematic Review and Meta-Analysis. [europepmc]
• Risks and use of ERCP during the diagnostic workup in a national cohort of biliary cancer. [europepmc]
• Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs. [europepmc]
• Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis? [europepmc]
• Early versus late pancreatic stent placement for preventing post-ERCP pancreatitis: protocol of a multicenter randomized clinical trial. [europepmc]
• Early intervention with rescue ERCP and pancreatic stenting for unanticipated post-ERCP pancreatitis: a comparative study. [europepmc]
• Prevention, Detection, and Management of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. [europepmc]
• Biliary and pancreatic stents. [europepmc]
• Short- and Long-Term Outcomes of Pancreatic ERCP in Pre-Teens: A Swedish Single Center Study. [europepmc]
• Short-term intravenous fluids for prevention of post-ERCP pancreatitis (the STRIPE study): protocol for a five-arm randomised controlled trial. [europepmc]